文献速递生殖医学

口服与经皮雌激素用于胚胎移植前子宫内膜准备:一项前瞻性、比较性、随机临床试验

Oral versus transdermal oestrogen delivery for endometrial preparation before embryo transfer: a prospective, comparative, randomized clinical trial.
PubMed 文献 · Reprod Biomed Online · 2018-09-29

这项前瞻性随机对照试验将140例患者分为口服戊酸雌二醇组和经皮半水合雌二醇贴片组,比较两种雌激素给药途径准备子宫内膜的效果。贴片组在治疗第10±1天子宫内膜更厚(7.6 mm vs 7.0 mm,P=0.026),且内膜厚度超过7 mm时血雌二醇水平更低(159.2 pg/ml vs 237.1 pg/ml,P<0.001)。口服组患者认为治疗更舒适、副作用更少,两组妊娠率、流产率和活产率无显著差异。

要点

  • 经皮雌激素组治疗第10±1天子宫内膜厚度显著高于口服组(7.6 mm vs 7.0 mm,P=0.026)。
  • 内膜厚度超过7 mm时,经皮组血雌二醇水平显著低于口服组(159.2 pg/ml vs 237.1 pg/ml,P<0.001)。
  • 口服组患者认为治疗更舒适且副作用更少,两组妊娠率、流产率和活产率无显著差异。

核心结论

  • 经皮雌激素治疗使患者在治疗10天后达到更高的子宫内膜厚度,同时血浆雌二醇水平更低,但耐受性不如口服途径。

研究设计与样本

  • 前瞻性随机对照试验,共随机分组140例患者,口服组采用戊酸雌二醇片方案,贴片组采用半水合雌二醇贴片方案。
  • 主要指标为治疗第10±1天的子宫内膜厚度;次要指标包括治疗第15±1天的子宫内膜厚度、患者满意度、血浆雌二醇水平、妊娠率、流产率和分娩率。
  • 若第10±1天子宫内膜厚度≤7 mm,则在第15±1天再次测量;在子宫内膜厚度>7 mm当天(第10±1天或第15±1天)检测血雌二醇水平。
  • 患者填写问卷评估舒适度和副作用。

主要发现

  • 贴片组在首次检查(第10±1天)时子宫内膜显著更厚(7.6 mm vs 7.0 mm,P=0.026)。
  • 当子宫内膜厚度超过7 mm时,贴片组血雌二醇水平显著低于口服组(159.2 pg/ml vs 237.1 pg/ml,P<0.001)。
  • 口服组认为治疗更舒适,副作用更少。
  • 两组妊娠率、流产率和活产率无显著差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: To determine whether the transdermal route is equal or superior to the oral route, when preparing the endometrium with oestrogens for embryo transfer. DESIGN: Prospective, randomized controlled trial; 140 patients randomized; the pills group followed a protocol with oestradiol valerate pills and the patches group followed a protocol with oestradiol hemihydrate patches. The primary variable was endometrial thickness on day 10 ± 1 of treatment. Secondary variables were endometrial thickness on day 15 ± 1 of treatment, patient satisfaction, plasma levels of oestradiol, rates of pregnancy, miscarriage and delivery. Endometrial thickness was measured on day 10 ± 1 of the cycle, if the lining was 7 mm or less in thickness, another measurement was made on day 15 ± 1. Blood oestradiol levels were analysed on the day the endometrial lining was greater than 7 mm (day 10 ± 1 or day 15 ± 1). Patients completed a survey to evaluate comfort and side-effects. RESULTS: The patches group achieved significantly thicker endometrium by the first check-up on day 10 ± 1 (7.6 mm versus 7.0 mm; P = 0.026), with lower blood levels of oestradiol (159.2 pg/ml versus 237.1 pg/ml; P < 0.001) when the endometrial thickness was over 7mm. The pills group considered the treatment more comfortable, with less side-effects. No significant differences in the rates of pregnancy, miscarriage or live birth were found. CONCLUSIONS: Transdermal oestrogen treatment allows patients to reach a higher endometrial thickness after 10 days of treatment, with lower plasma levels of oestradiol, although it is not tolerated as well.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Ferrer-Molina P, Calatayud-Lliso C, Carreras-Collado R, et al. Oral versus transdermal oestrogen delivery for endometrial preparation before embryo transfer: a prospective, comparative, randomized clinical trial. Reprod Biomed Online. 2018. PMID: 30340939. doi:10.1016/j.rbmo.2018.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。